President Trump will announce that the FDA will issue an emergency authorization for blood plasma as a coronavirus treatment, Politico reports.
“The agency held off on the decision last week over concerns from government scientists that evidence for the treatment’s effectiveness is thin — prompting Trump to accuse the FDA of slow-walking the therapy to harm his reelection chances without offering any evidence to support his claim.”
Washington Post: “Many scientists and physicians believe that convalescent plasma might provide some benefit but is far from a breakthrough. It is rich in antibodies that could be helpful in fighting the coronavirus, but the evidence so far has not been conclusive about whether it works, when to administer it and what dose is needed.”
